Condition: Lung Cancer · Sponsor: Zhen-Yu Ding
This is a single-center, single-arm, prospective clinical trial to investigate the safety and efficacy of Neo-DCVac combined with ICIs in the treatment of advanced lung cancer resistant to ICIs.
This description comes directly from the study's public registry record.
Zhengyu Ding, MD · 18980601957 · dingzhenyu@scu.edu.cn
Qing Li, MD · 18702848178 · liqing@scu.edu.cn
Always discuss trial participation with your own doctor first.
| West China Hospital | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06329908